91 results
8-K
EX-10.1
KPTI
Karyopharm Therapeutics Inc
14 May 24
Other Events
4:06pm
. As of the Closing Date, neither the Company nor any of its Subsidiaries has any contingent liability or liability for taxes, long-term lease or unusual … forward or long-term commitment that is not reflected in the Historical Financial Statements or the notes thereto and that in any such case would
8-K
EX-99.1
KPTI
Karyopharm Therapeutics Inc
8 May 24
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
7:47am
treatments.
R&D Highlights
Endometrial Cancer
Invited to present updated long-term follow-up data of selinexor in patients with TP53 wild-type advanced … Plenary Series: Rapid Abstract Updates” session in June 2024.
Long-term follow-up data from a pre-specified exploratory subgroup analysis of patients
SC TO-C
EX-99.2
e9nklm32g22qz 9c9bl
8 Apr 24
Information about tender offer
5:08pm
8-K
EX-99.1
q0a 6zthaux
29 Feb 24
Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
7:35am
8-K
EX-99.1
ocz09pydfu bfl
8 Jan 24
Karyopharm Announces Preliminary Unaudited 2023 Revenue and 2024 Objectives
8:40am
8-K
EX-99.1
qct2ohukiyxdtd
2 Nov 23
Karyopharm Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
7:37am
8-K
EX-99.1
6ha9e
2 Aug 23
Karyopharm Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
7:37am